Trigeminal Nerve Stimulation an Option for ADHD? May 20, 2013 http://www.medscape.com/viewarticle/804440
Currently, the system has no approvals in the United States from the US Food and Drug Administration (FDA).
Leon Ekchian, president and CEO of NeuroSigma, Inc, said the company plans first to apply for the epilepsy indication in the United States, with depression next and ADHD indications probably further down the road.
An external trigeminal nerve stimulation (eTNS) system (Monarch, NeuroSigma, Inc) has received European Union (EU) CE Certification for the adjunctive treatment of epilepsy and major depressive disorder for adults and children aged 9 years and older.
The device has been evaluated in clinical trials conducted at the University of California, Los Angeles (UCLA) and the University of Southern California. It consists of an external pulse generator and disposable electric patches placed on the forehead that are replaced daily and are worn primarily during sleep.
frequent or prolonged seizures can eventually cause problems with memory and thinking.
seizures “can actually change the way language centers in the brain develop.”
low-carbohydrate diets, including the high-fat ketogenic diet
Then there are new implanted devices that send electrical signals to the vagus nerve
to provide parents and other caregivers with an emergency kit that lets them administer a fast-acting drug to stop a seizure.
“Epilepsy surgery is underutilized in this country,”
For about 30 percent of children with epilepsy, none of the existing treatments is adequate.
transplanting a type of cell that reduces excessive electrical activity in the brain. “Stem Cell therapy may be one way that we can very specifically target the region of the brain that is overexcited and quiet that area of the brain.”
Another experimental approach involves devices that monitor the brain for abnormal activity.
Some are able to predict when the brain activity is headed toward a seizure, Fureman says, “and actually deliver stimulation that shuts down that seizure activity.”